BioSpace News Archive

The American Cancer Society honors the winners of the 2020 American Cancer Society Volunteer Staff Partnership Award, a national honor in recognition of a volunteer and staff team that has positively impacted the American Cancer Society mission.

Enzychem Lifesciences (KOSDAQ: 183490), a clinical-stage biopharmaceutical company developing innovative medicines to improve the lives of patients with cancer and inflammatory diseases, today announced that an Enzychem Lifesciences representative will be participating as a panelist at the 15 th New York Health Forum

VANCOUVER, BC, March 11, 2021 /PRNewswire/ - CRH Medical Corporation announces a startup joint venture where CRH owns a 51% interest in a gastroenterology anesthesia practice located in Largo, Florida.

DiscernDx, a precision multi-omics diagnostics company, announced preliminary study results evaluating their non-invasive liquid biopsy test for diagnosing early stages of nonalcoholic steatohepatitis (NASH). The results illustrated the novel combination of multi-omics and machine learning for NASH diagnosis as an alternative to liver biopsy.

Proscia®, a leading provider of digital and computational pathology solutions, and Ibex Medical Analytics, the pioneer in artificial intelligence (AI)-based cancer diagnostics, have entered into a strategic partnership to support pathologists in detecting prostate cancer, the second leading cause of cancer death among men in the United States

American CryoStem Corporation a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing and therapies announced that it has begun processing patient’s adipose tissue and culturing mesenchymal stem cells, for use in its FDA approved IND Phase I Clinical Trial.

Validates multi-omics techniques for measuring therapeutic responses to AML, holding promise for future blood cancer treatments